Document is current
Any future updates will be listed below
-
Authors
Nakano, Yuko
Gamper, Howard https://orcid.org/0000-0001-9007-8546
McGuigan, Henri
Maharjan, Sunita https://orcid.org/0000-0002-7099-1802
Li, Jiatong https://orcid.org/0009-0007-3894-9843
Sun, Zhiyi https://orcid.org/0000-0002-6106-5356
Yigit, Erbay https://orcid.org/0000-0003-2637-4994
Grünberg, Sebastian https://orcid.org/0000-0002-5694-0574
Krishnan, Keerthana
Li, Nan-Sheng
Piccirilli, Joseph A. https://orcid.org/0000-0002-0541-6270
Kleiner, Ralph https://orcid.org/0000-0003-0508-9975
Nichols, Nicole
Gregory, Brian D. https://orcid.org/0000-0001-7532-0138
Hou, Ya-Ming https://orcid.org/0000-0001-6546-2597
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM134931, GM149336, GM132189)
National Science Foundation (MCB-2427729)
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 14 January 2025
First Online: 26 January 2025
Competing interests
: Y.N., H.G., H.M, S.M, J.L., N.S.L., J.A.P., R.K, B.D.G., and Y.M.H. declare no competing interests. Z.S., K.K., E.Y., S.G., and N.N. are employees of New England Biolabs, Inc., where Z.S. performed data analysis, K.K. and S.G. performed Illumina sequencing of tRNAseq libraries, and E.Y. and N.N. provided discussion. New England Biolabs is a manufacturer and vendor of molecular biology reagents, including Induro, Rnl2, T4 PNK, restriction enzymes, and several buffers used in this study. These authors declare no competing interests. The affiliation of Z.S., K.K., E.Y., S.G., and N.N. with New England Biolabs does not affect these authors’ impartiality, adherence to journal standards and policies, or objective data presentation, analysis, and interpretation.
